Sign In

Statement on Disclosure

AASLD is an accredited provider of continuing medical education and adheres to the policies and standards set forth by the Accreditation Council for Continuing Medical Education (ACCME). As such, all faculty members (including Program Planners, Program Chairs, Moderators, Panelists, and Presenters) and abstract authors are expected to fully disclose all financial relationships with commercial interests during the past 12 months. A commercial interest is defined as "any entity developing, producing, marketing, re-selling or distributing healthcare goods or services consumed by or used on patients."

To ensure compliance, AASLD expects that all program content and related materials will promote improvements or quality in health care and not a specific proprietary business interest or commercial bias.

AASLD staff and program committees reserve the right to change an abstract if the use of a trade name may be mistaken for commercial propaganda and may replace proprietary names with generic names. Logos promoting a commercial interest will be removed from any and all slides before presentation.

COI Review, Management and Resolution

AASLD, in collaboration with The Liver Meeting® Program Chairs and Planning Committees will review all faculty and abstract presenter disclosures prior to the meeting. Any potential conflicts of interest will be managed via the following:

  • Slide Review* one – two months prior to the meeting.
  • Slide Review* as noted above, with an onsite audit of the presentation at the meeting.

*Presenters must comply with requests to submit their slides one – two months prior to the meeting. Any slides not received may result in the removal of your presentation from the program. At the conclusion of the slide review, presenters may be asked to alter the content of their presentation to ensure balance and eliminate any perception(s) of commercial bias.

All faculty member disclosures will appear in the Final Program, in The Liver Meeting® app and as the first slide of each presentation that will be provided by AASLD.

CME Content Validation

AASLD follows the ACCME policy on content validation for CME activities which requires:

  • All the recommendations involving clinical medicine in a CME activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients.
  • All scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection and analysis.

Off-Label / Investigational Use Policy

When an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, the presenter shall disclose to the audience that the product is not labeled for the use under discussion or that the product is still being investigational, in accordance with the ACCME standards and the Food and Drug Administration requirements.


All faculty members (including Program Planners, Program Chairs, Moderators, Panelists, and Presenters) and abstract authors from The Liver Meeting® are expected to fully disclose all financial relationships with commercial interests during the past 12 months. Disclosures from The Liver Meeting® 2019 faculty will be provided in early November.

  • Faculty Disclosures [Excel]
  • Committee Disclosures [Excel]

Glossary of Terms

Commercial Interest: A commercial interest is defined as any entity producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients.

Financial Relationships: The ACCME requires anyone in control of CME content to disclose relevant financial relationships to the accredited provider. Individuals must also include in their disclosure the relevant financial relationships of a spouse or partner. The ACCME defines relevant financial relationships as financial relationships in any amount that create a conflict of interest and that occurred in the twelve-month period preceding the time that the individual was asked to assume a role controlling content of the CME activity. The ACCME has not set a minimal dollar amount—any amount, regardless of how small, creates the incentive to maintain or increase the value of the relationship. Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria for promotional speakers’ bureau, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.

Relevant Financial Relationships: The ACCME defines "'relevant' financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.

Financial Conflict of Interest: The ACCME considers financial relationships to create conflicts of interest in CME when individuals have both a financial relationship with a commercial interest and the opportunity to affect the content of CME about the products or services of that commercial interest. The potential for maintaining or increasing the value of the financial relationship with the commercial interest creates an incentive to influence the content of the CME—an incentive to insert commercial bias.